Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 4:05 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2113–2136 of 29,052 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Disease;Neurological Clear all

Conditions: Down Syndrome
Interventions: Placebo, RG1662; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 12 Years to 30 Years
Enrollment: 173 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 9
States / cities: La Jolla, California • Sacramento, California • Decatur, Georgia + 6 more

Conditions: Insomnia, Suicidal Ideation, Suicide, Attempted
Interventions: TAILOR, Enhanced Usual Care; Behavioral · Other
Lead sponsor: Jeff Bridge; Other
Eligibility: 11 Years to 18 Years
Enrollment: 235 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Migraine
Interventions: Mixed meal tolerance testing, Skin conductance & cold pressor test, Flow-mediated dilation testing; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2026
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania

Conditions: Stroke
Interventions: Belt Accelerations, Belt accelerations combined with an exoskeleton, Variable Stiffness treadmill; Behavioral
Lead sponsor: University of Delaware; Other
Eligibility: 18 Years to 80 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Cerebral Palsy
Interventions: Partial body weight support treadmill training, Exercise; Behavioral
Lead sponsor: Shriners Hospitals for Children; Other
Eligibility: 6 Years to 13 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 3
States / cities: Shreveport, Louisiana • St Louis, Missouri • Philadelphia, Pennsylvania

Conditions: Myalgic Encephalomyelitis, Chronic Fatigue Syndrome
Interventions: No Intervention; Other
Lead sponsor: ProgenaBiome; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2030
U.S. locations: 1
States / cities: Ventura, California

Conditions: Hypogonadism, Precocious Puberty
Interventions: Not listed
Lead sponsor: National Center for Research Resources (NCRR); NIH
Eligibility: 7 Years to 35 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 1993
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Depression, Anhedonia
Interventions: Active RS-EFP, Sham RS-EFP; Device
Lead sponsor: GrayMatters Health Ltd.; Industry
Eligibility: 22 Years to 65 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Anxiety Disorder, Cognitive/Functional Effects, Colorectal Cancer, Depression, Fatigue, Psychosocial Effects of Cancer and Its Treatment, Sleep Disorders, Excercise
Interventions: exercise intervention, counseling intervention, Educational Intervention, laboratory biomarker analysis, questionnaire administration, study of socioeconomic and demographic variables, fatigue assessment and management, quality-of-life assessment, Fitness testing; Behavioral · Other · Procedure
Lead sponsor: Canadian Cancer Trials Group; Network
Eligibility: 18 Years and older
Enrollment: 889 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2026
U.S. locations: 3
States / cities: Detroit, Michigan • Lebanon, New Hampshire • Chapel Hill, North Carolina

Conditions: Stroke
Interventions: Mobile Service Robot Survey, Mobile Service Robot Survey for Patients; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Severe Pain, Cesarean Section Complications, Postpartum, Chronic Pain, Acute Postoperative Pain
Interventions: Empowered Relief; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Parkinson's Disease
Interventions: CogSMART-PD, Supportive Care; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 40 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: San Diego, California

Conditions: Growth Hormone Deficiency, Dwarfism
Interventions: Dextromethorphan and Caffeine; Drug
Lead sponsor: University of Louisville; Other
Eligibility: 4 Years to 14 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2008
U.S. locations: 4
States / cities: San Diego, California • Louisville, Kentucky • Kansas City, Missouri + 1 more

Conditions: Fibromyalgia
Interventions: Percutaneous electrical nerve field stimulation; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Decatur, Georgia

Conditions: Alzheimer Disease, Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD)
Interventions: natural product combination-1 (NPC1); Combination Product
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 55 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Insomnia, Mental Health Disorder, Substance Use Disorder
Interventions: Quetiapine, Trazodone; Drug
Lead sponsor: VA Connecticut Healthcare System; Federal
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Hemorrhage, Gastrointestinal, Myocardial Infarction, Stroke, Kidney Diseases
Interventions: Not listed
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 144,337 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Raritan, New Jersey

Conditions: Alzheimer Disease
Interventions: Tau Positron emission tomography (PET), Fluorodeoxyglucose (FDG) Positron emission tomography (PET), Cerebrospinal fluid (CSF) Biomarkers, Blood Biomarkers, Rating Scales, PU-AD, Placebo; Radiation · Diagnostic Test · Behavioral + 1 more
Lead sponsor: Samus Therapeutics, Inc.; Industry
Eligibility: 55 Years to 80 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 10
States / cities: Boca Raton, Florida • Delray Beach, Florida • Lake Worth, Florida + 6 more

Conditions: Post Traumatic Stress Disorder, Traumatic Brain Injury
Interventions: Cool B70 AP Coil - Active (dl-PFC), Cool B70 AP Coil- Sham (dl-PFC), Cool D-B80 AP Coil - Active (dm-PFC), Cool D-B80 AP Coil - Sham (dm-PFC), Cool B70 Treatment Coil - Active Only; Device
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Fabry Disease
Interventions: PRX-102 (pegunigalsidase alfa), agalsidase beta; Biological
Lead sponsor: Protalix; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 15
States / cities: Birmingham, Alabama • Phoenix, Arizona • Orange, California + 11 more

Conditions: Spinal Cord Injuries
Interventions: Transcutaneous Spinal Cord Stimulation and Gait Training; Other
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 18 Years to 65 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pelvic Pain Associated With Refractory Endometriosis
Interventions: BGS649, Placebo; Drug
Lead sponsor: Mereo BioPharma; Industry
Eligibility: 18 Years to 49 Years · Female only
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 42
States / cities: Mobile, Alabama • Phoenix, Arizona • Jonesboro, Arkansas + 36 more

Conditions: Brain Cancer, Brain Stem Tumors, Pontine Tumors
Interventions: Rindopepimut; Biological
Lead sponsor: Paul Graham Fisher; Other
Eligibility: 3 Years to 18 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Stanford, California

Conditions: Carpal Tunnel Syndrome
Interventions: Fisetin; Drug
Lead sponsor: Peter C. Amadio, M.D.; Other
Eligibility: 21 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Search by objective public record fields.

A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS)

Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior

Migraine and CVD Risk in Women

Model-informed Patient-specific Rehabilitation Using Robotics and Neuromuscular Modeling

Supported Speed Treadmill Training Exercise Program (SSTTEP) for Marginally Ambulatory Children With Cerebral Palsy

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in ME/CFS

Study of Gonadotropin-Releasing Hormone Pulse Frequency in Sexual Maturation and in the Menstrual Cycle

PRISM Neurofeedback Training for MDD Anhedonic Patients

Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

Mobile Service Robot for Task-Oriented Stroke Therapy: User Evaluations

Empowered Relief for Severe Pain After Cesarean Delivery During the Inpatient Period

Cognitive Rehabilitation for PD

rhGH Therapy on Hepatic Drug Metabolism

Auricular Neuromodulation in Veterans With Fibromyalgia

Biomarker-based Trial of NPC-1 for Alzheimer's Pathology

Comparison of Quetiapine and Trazodone Treatment for Insomnia in Dually Diagnosed Veterans

A Study of Channeling in the Use of Nonprescription Paracetamol and Ibuprofen in an Electronic Medical Records Database: Evidence and Implications

To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Dementia

Rapid Treatment of PTSD With Accelerated Non-Invasive Brain Stimulation

Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function

The Impact of Transcutaneous Spinal Cord Stimulation (TSCS) and Gait Training on Walking Function in Patients With Spinal Cord Injury

A Safety & Efficacy Study of BGS649 in Women With Refractory Endometriosis

Phase I Rindopepimut After Conventional Radiation in Children w/ Diffuse Intrinsic Pontine Gliomas

A Study of Fisetin to Treat Carpal Tunnel Syndrome